May 1, 2020 / 9:27 PM / a month ago

BRIEF-Sunesis Pharmaceuticals - Appointed Dayton Misfeldt, Co's Interim CEO, As Principal Financial Officer

May 1 (Reuters) - Sunesis Pharmaceuticals Inc:

* SUNESIS PHARMACEUTICALS - ON APRIL 28, APPOINTED DAYTON MISFELDT, CO'S INTERIM CEO, AS PRINCIPAL FINANCIAL OFFICER & SECRETARY, EFFECTIVE MAY 1, 2020 Source text for Eikon: bit.ly/2YB4gfx Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below